At a glance
- Originator Georgia Institute of Technology; National Cancer Institute (USA)
- Class Antivirals; Organic chemicals; Stilbenes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 21 Mar 1995 No-Development-Reported for HIV infections treatment in USA (Unknown route)